Taiwanese Journal of Obstetrics and Gynecology
Volume 46, Issue 2 , Pages 127-134 , June 2007

Standard and Low-dose Hormone Therapy for Postmenopausal Women—Focus on the Breast

,Accepted 12 January 2007.

References 

  1. Rowe T , Blake J , Belisle S . Introduction. Canadian Consensus Conference on Menopause, 2006 update . J Obstet Gynaecol Can . 2006;28(Special Edition 1):S13–S20
  2. Wang PH , Cheng MH , Chao HT , Chao KC . Effects of tibolone on the breast of postmenopausal women . Taiwan J Obstet Gynecol . 2007;46:121–126
  3. Practice Committee of the American Society for Reproductive Medicine  . Estrogen and progestogen therapy in postmenopausal women . Fertil Steril . 2006;86(Suppl 1):S75–S88
  4. Chao KC, Wang PH, Yen MS, Chang CY, Juang CM, Twu NF, et al. New selective tissue estrogenic activity regulator (STEAR) in menopausal therapy in Taiwan . Taiwanese J Obstet Gynecol . 2005;44:327–331
  5. Practice Committee of the American Society for Reproductive Medicine  . The menopausal transition . Fertil Steril . 2006;86(Suppl 1):S253–S256
  6. ESHRE Capri Workshop Group  . Hormones and breast cancer . Hum Reprod Update . 2004;10:281–293
  7. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer . Lancet . 1997;350:1047–1059
  8. Collins JA , Blake JM , Crosignani PG . Breast cancer risk with postmenopausal hormonal treatment . Hum Reprod Update . 2005;11:545–560
  9. Ferreira E , Brown TER . Therapeutics: prescription drugs . J Obstet Gynaecol Can . 2006;28(Special edition 1):S61–S67
  10. Loose-Mitchell DS , Stancel GM . Estrogens and progestins . In:  Hardman JG ,  Limbird LE ,  Gilman AG editor. Goodman & Gilman's The Pharmacological Basis of Therapeutics . 10th editionxs. Toronto: McGraw-Hill; 2001;p. 1597–1637
  11. van de Weijer PH , Mattsson LA , Ylikorkala O . Benefits and risks of long-term low-dose oral continuous combined hormone therapy . Maturitas . 2007;56:231–248
  12. Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, et al. Classification and pharmacology of progestins . Maturitas . 2003;46(Suppl 1):S7–S16
  13. Sitruk-Ware R . Progestins in the menopause . J Steroid Biochem Mol Biol . 1999;69:185–193
  14. Graziottin A . Libido: the biologic scenario . Maturitas . 2000;34(Suppl 1):S9–S16
  15. Sitruk-Ware R . Pharmacological profile of progestins . Maturitas . 2004;47:277–283
  16. Lobo RA . Absorption and metabolic effects of different types of estrogens and progestogens . Obstet Gynecol Clin North Am . 1987;14:143–167
  17. Palacios S , Foidart JM , Genazzani AR . Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism . Maturitas . 2006;55:297–307
  18. Desindes S , Belisle S , Graves G . Menopause and age-related concerns . J Obstet Gynaecol Can . 2006;28(Special edition 1):S21–S32
  19. MacLennan A , Lester S , Moore V . Oral oestrogen replacement therapy versus placebo for hot flushes . Cochrane Database Syst Rev . 2001;1:CD002978
  20. Barnabei VM , Cochrane BB , Aragaki AK , Nygaard I , Williams RS , McGovern PG , et al.   Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative . Obstet Gynecol . 2005;105:1063–1073
  21. Samsioe G . Transdermal hormone therapy: gels and patches . Climacteric . 2004;7(4):347–356
  22. Utian WH , Shoupe D , Bachmann G , Pinkerton JV , Pickar JH . Relief of vasomotor symptoms and vaginal atrophy with low doses of conjugated equine estrogens and medroxyprogesterone acetate . Fertil Steril . 2001;75:1065–1079
  23. Rodstrom K , Bengtsson C , Lissner L , Milsom I , Sundh V , Bjorkelund C . A longitudinal study of the treatment of hot flushes: The population study of women in Gothen-burg during a quarter of a century . Menopause . 2002;9:156–161
  24. Crandall C . Low-dose estrogen therapy for menopausal women: a review of efficacy and safety . J Womens Health . 2003;12:723–747
  25. Cherry N , Gilmour K , Hannaford P , Heagerty A , Khan MA , Kitchener H , et al.   Oestrogen therapy for prevention of rein-farction in postmenopausal women: a randomised placebo controlled trial . Lancet . 2002;360:2001–2008
  26. Hodis HN , Mack WJ , Azen SP , Lobo RA , Shoupe D , Mahrer PR , et al.   Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women . N Engl J Med . 2003;349:535–545
  27. Viscoli CM , Brass LM , Kernan WN , Sarrel PM , Suissa S , Horwitz RI . A clinical trial of estrogen-replacement therapy after ischemic stroke . N Engl J Med . 2001;345:1243–1249
  28. Stefanick ML , Anderson GL , Margolis KL , Hendrix SL , Rodabough RJ , Paskett ED , et al.   Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy . JAMA . 2006;295:1647–1657
  29. Nachtigall LE , Nachtigall RH , Nachtigall RD , Beckman EM . Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems . Obstet Gynecol . 1979;54:74–78
  30. Angerer P , Stork S , Kothny W , Schmitt P , von Schacky C . Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: a randomized, controlled trial . Arterioscler Thromb Vasc Biol . 2001;21:262–268
  31. Hulley S , Furberg C , Barrett-Connor E , Cauley J , Grady D , Haskell W , et al.   Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and estrogen/progestin replacement study follow-up (HERS II) . JAMA . 2002;288:58–66
  32. Chlebowski RT , Hendrix SL , Langer RD , Stefanick ML , Gass M , Lane D , et al.   Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative Randomized Trial . JAMA . 2003;289:3243–3253
  33. Writing Group for the Women's Health Initiative Investigators  . Risks and benefits of estrogen plus progestin in healthy postmenopausal women . JAMA . 2002;288:321–333
  34. Beral V . Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study . Lancet . 2003;362:419–427
  35. Kaaks R , Berrino F , Key T , Rinaldi S , Dossus L , Biessy C , et al.   Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC) . J Natl Cancer Inst . 2005;97:755–765
  36. Missmer SA , Eliassen AH , Barbieri RL , Hankinson SE . Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women . J Natl Cancer Inst . 2004;96:1856–1865
  37. Tworoger SS , Missmer SA , Barbieri RL , Willett WC , Colditz GA , Hankinson SE . Plasma sex hormone concentrations and subsequent risk of breast cancer among women using post-menopausal hormones . J Natl Cancer Inst . 2005;97:595–602
  38. Shanafelt TD , Barton LB , Adjei AA , Loprinzi CL . Patho-physiology and treatment of hot flashes . Mayo Clin Proc . 2002;77:1207–1218
  39. Gold EB , Sternfeld B , Kelsey JL , Brown C , Mouton C , Reame N , et al.   Relation of demographic and lifestyle factors to symptoms in a multiracial ethnic population of women 40–55 years of age . Am J Epidemiol . 2000;152:463–473
  40. MacLennan A , Lester S , Moore V . Oral estrogen replacement therapy versus placebo for hot flushes (Cochrane Review) . Cochrane Database Syst Rev . 2001;1:CD002978
  41. MacLennan AH , MacLennan A , Wenzel S , Chambers HM , Eckert K . Continuous low-dose oestrogen and progestogen hormone replacement therapy: a randomised trial . Med J Aust . 1993;159:102–106
  42. Loh FH , Chen LH , Yu SL , Jorgensen LN . The efficacy of two dosages of a continuous combined hormone replacement regimen . Maturitas . 2002;41:123–131
  43. Baerug U , Winge T , Nordland G , et al.   Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms? . Climacteric . 1998;1:219–228
  44. Schurmann R , Holler T , Benda N . Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens . Climacteric . 2004;7:189–196
  45. Speroff L , Symons J , Kempfert N , Rowan J , for the Femhrt Study Investigators  . The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt) on the frequency and intensity of vasomotor symptoms . Menopause . 2000;7:383–390
  46. Greendale GA , Reboussin BA , Slone S , Wasilauskas C , Pike MC , Ursin G . Postmenopausal hormone therapy and change in mammographic density . J Natl Cancer Inst . 2003;95:30–37
  47. McTiernan A , Martin CF , Peck JD , et al.   Estrogen-plusprogestin use and mammographic density in postmenopausal women: women's health initiative randomized trial . J Natl Cancer Inst . 2005;97:1366–1376
  48. Lundstrom E , Wilczek B , von Palffy Z , Soderqvist G , von Schoultz B . Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens . Climacteric . 2001;4:42–48
  49. Sendag F, Cosan Terek M, Ozsener S, Oztekin K, Bilgin O, Bilgen I, et al. Mammographic density changes during different postmenopausal hormone replacement therapies . Fertil Steril . 2001;76:445–450
  50. Christodoulakos GE, Lambrinoudaki IV, Vourtsi AD, Vlachou S, Creatsa M, Panoulis KP, et al. The effect of low-dose hormone therapy on mammographic breast density . Maturitas . 2006;54:78–85
  51. Conner P , Svane G , Azavedo E , et al.   Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy . Fertil Steril . 2004;81:1617–1623
  52. Lundstrom E , Soderqvist G , Svane G , et al.   Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate: a pilot study . Fertil Steril . 2006;85:989–995
  53. Junkermann H , von Holst T , Lang E , Rakov V . Influence of different HRT regimens on mammographic density . Maturitas . 2005;50:105–110

PII: S1028-4559(07)60006-0

doi: 10.1016/S1028-4559(07)60006-0

Taiwanese Journal of Obstetrics and Gynecology
Volume 46, Issue 2 , Pages 127-134 , June 2007

Article Tools